MYOR:IDXPT Mayora Indah Tbk Analysis
Data as of 2026-07-09 - not real-time
IDR 1,730.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Mayora’s shares are trading at IDR 1,730, well below the 30‑day DCF fair value of IDR 2,394, implying a potential upside of over 50 %. The price sits beneath the 20‑day SMA (IDR 1,794) and the 50‑day SMA (IDR 1,786), while the MACD line remains deeply negative (-11.39) against a flat signal line, signalling bearish momentum in the short run. However, the RSI at 44 suggests the stock is not yet oversold, and the neutral trend line indicates no decisive directional bias at present. Volume is on a decreasing trajectory, which may limit short‑term price swings, but the beta of 0.22 points to low systematic risk. On the fundamentals side, Mayora delivers a solid 3.48 % dividend yield with a modest 39 % payout ratio, strong operating cash flow (IDR 5.6 tn) and free cash flow (IDR 4.1 tn), and a healthy ROE of 17 %. The company’s PE of 12.4x and forward PE of 10.8x are attractive relative to its peers, while the price‑to‑book of 2.0x aligns with its asset base. The fear‑greed index sits at “Extreme Greed” (93.14), reflecting strong market appetite for risk‑on assets, which could further buoy demand for undervalued defensive stocks like Mayora.
Overall, the valuation gap, robust cash generation, and sustainable dividend make Mayora an appealing value play, though the current technical setup advises caution. Investors should monitor the support at IDR 1,605 and the resistance near IDR 1,990, while keeping an eye on volume trends and any macro‑economic shifts in Indonesia that could affect consumer spending.
Overall, the valuation gap, robust cash generation, and sustainable dividend make Mayora an appealing value play, though the current technical setup advises caution. Investors should monitor the support at IDR 1,605 and the resistance near IDR 1,990, while keeping an eye on volume trends and any macro‑economic shifts in Indonesia that could affect consumer spending.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram
- Price below 20‑day SMA
- Decreasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF upside of >50 %
- Strong cash flow and low debt ratio
- Attractive dividend yield with sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Defensive consumer staples positioning
- Consistent profitability and ROE
- Long‑term valuation gap relative to fair value
Key Metrics & Analysis
Financial Health
Revenue Growth-4.70%
Profit Margin8.17%
P/E Ratio12.4
ROE17.13%
ROA8.78%
Debt/Equity26.63
P/B Ratio2.0
Op. Cash FlowIDR5617.7B
Free Cash FlowIDR4064.8B
Technical Analysis
TrendNeutral
RSI44.3
SupportIDR 1,605.00
ResistanceIDR 1,990.00
MA 20IDR 1,794.25
MA 50IDR 1,786.20
MA 200IDR 2,017.30
MACDBearish
VolumeDecreasing
Fear & Greed Index93.14
Valuation
Fair ValueIDR 2,394.09
Target PriceIDR 2,630.00
Upside/Downside52.02%
GradeUndervalued
TypeValue
Dividend Yield3.48%
Risk Assessment
Beta0.22
Volatility55.60%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.